| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 16.308 | 66.102 | 79.041 | 86.532 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 16.308 | 81.685 | 97.166 | 86.559 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 7.268 | 10.231 | 55.922 | 75.879 | 72.265 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -7.268 | 6.077 | 25.763 | 21.287 | 14.293 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -7.268 | 5.586 | 24.429 | 20.461 | 12.751 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bioconstruct Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.089 | 1.078 | 1.059 | 1.040 | 42 | 41 | 0 | 4.009 | 10.822 | 18.143 |
| Current Assets | 26 | 26 | 25 | 25 | 11 | 13.989 | 3.359 | 11.088 | 37.977 | 36.451 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 13.571 | 1.028 | 1.176 | 4.558 | 1.484 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 154 | 1.616 | 18.394 | 351 |
| Cash | 26 | 26 | 25 | 25 | 11 | 418 | 2.177 | 8.296 | 15.026 | 34.617 |
| Shareholders Funds | -2.479 | -2.453 | -2.412 | -2.368 | -432 | -7.650 | -1.502 | 22.923 | 43.314 | 51.803 |
| Social Capital | 45 | 45 | 44 | 43 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.593 | 3.557 | 3.496 | 3.432 | 485 | 21.680 | 17.770 | 14.687 | 13.267 | 2.792 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Bioconstruct Srl